The Faculty of Medicine: Innovation Changing Lives
Prof. Alexander Levitzki of the Hebrew University's Department of Biological Chemistry is the recipient of the 2013 American Association for Cancer Research Award for Outstanding Achievement in Chemistry in Cancer Research. Prof. Levitzki is a pioneer of targeted cancer therapy whose work in signal transduction therapy and development of tyrosine kinase inhibitors is used in numerous anticancer drugs worldwide.
Prof. Michal Baniyash and doctoral student Moshe Sade-Feldman of the Lautenberg Center for General and Tumor Immunology at the Institute for Medical Research Israel-Canada have discovered that a factor assisting the immune system can turn into an agent for suppressing the same system. The researchers determined the underlying mechanisms of the factor and its part in the development of immune suppression during chronic inflammation.More
A study conducted by doctoral student Vered Ben-Hur in the lab of Dr. Rotem Karni at the Hebrew University’s Institute of Medical Research Israel-Canada (IMRIC) has shown that breast cancer cells change the alternative splicing of an important enzyme involved in the transmission of information into the cell. The researchers’ discovery provides a valuable marker for the early diagnosis and follow-up treatment of malignant growths.More
January 13, 2013: Prof. Ron Kohen of the Hebrew University's Institute of Drug Research has found that antioxidants in red wine can diminish the unhealthy effects of eating red meat. He told The Daily Telegraph that including products rich in polyphenol — such as red wine — can prevent the build-up of cholesterol after a meal of dark or red meat.More
In basic research, Dr. Shirley Weiss and Prof. Baruch Minke of the Hebrew University’s Institute of Medical Research Israel-Canada (IMRIC) and Edmond and Lily Safra Center for Brain Sciences (ELSC) — with colleagues in Israel and the US — have identified a cellular mechanism which is essential for maintaining healthy levels of cellular calcium. This new understanding of the fundamental mechanisms underlying cellular calcium regulation is critical for the development of drugs and treatments for neurodegenerative diseases.More
January 1, 2013: As reported in The New York Times, the Hebrew University’s Prof. Raphael Mechoulam and Prof. Ruth Gallily have been at the vanguard of research into the medicinal properties of cannabis for decades. At age 82, Mechoulam continues to collaborate with research teams around the world. He expects that, within the next few years, today’s medicinal marijuana will be replaced by well-defined mixtures of isolated compounds which have been refined into something more like a medical drug.More